Total synthesis of antiviral drug, nirmatrelvir (PF-07321332)

Shekhar, Chandra ; Nasam, Rajesh ; Paipuri, Siva Ramakrishna ; Kumar, Prakash ; Nayani, Kiranmai ; Pabbaraja, Srihari ; Mainkar, Prathama S. ; Chandrasekhar, Srivari (2022) Total synthesis of antiviral drug, nirmatrelvir (PF-07321332) Tetrahedron Chem, 4 . p. 100033. ISSN 2666951X

[img] PDF
635kB

Official URL: http://doi.org/10.1016/j.tchem.2022.100033

Related URL: http://dx.doi.org/10.1016/j.tchem.2022.100033

Abstract

The emergence and rapid spread of coronavirus disease 2019 (COVID-19), a potentially fatal disease, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has swiftly led to public health crisis worldwide. Hence vaccines and antiviral therapeutics are an important part of the healthcare response to combat the ongoing threat by COVID-19. Here, we report an efficient synthesis of nirmatrelvir (PF-07321332), an orally active SARS-CoV-2 main protease inhibitor.

Item Type:Article
Source:Copyright of this article belongs to Elsevier Inc
Keywords:Antiviral drug;COVID-19;Peptide;Protein mimetic;Amino acid;Peptide coupling;Cyclopropanation
ID Code:131261
Deposited On:06 Dec 2022 08:28
Last Modified:06 Dec 2022 08:28

Repository Staff Only: item control page